VSTM – verastem, inc. (US:NASDAQ)
Stock Stats
News
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Verastem (VSTM) had its "buy" rating reaffirmed by Jefferies Financial Group Inc.. They now have a $15.00 price target on the stock, down from $19.00.
Verastem: Maintaining "Buy" As 1st Half 2026 Catalysts In Play [Seeking Alpha]
Verastem Oncology Announces Late Breaking and Regular Abstracts Accepted for Presentation at the AACR Annual Meeting 2026
Verastem Oncology Announces Abstracts Accepted for Presentation on AVMAPKI™ FAKZYNJA™ (avutometinib capsules; defactinib tablets) Combination Therapy at the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancers [Yahoo! Finance]
Form SCHEDULE 13G/A Verastem, Inc. Filed by: VANGUARD GROUP INC
Form 4 Verastem, Inc. For: Mar 20 Filed by: Calkins Daniel
Form 8-K Verastem, Inc. For: Mar 04
Form 10-K Verastem, Inc. For: Dec 31
Form SCHEDULE 13G Verastem, Inc. Filed by: ARMISTICE CAPITAL, LLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.